US4312878A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of eliminating opiate withdrawal symptoms with clonidine in humans
Assignee: Boehringer Ingelheim International GmbH
•
Filing: 1980-07-10
•
Granted: 1982-01-26
•
Expires: 2000-07-10
Abstract
Abstract A method of eliminating opiate withdrawal symptoms in human opiate addicts by oral administration of clonidine.
Inventors
- 👤 Donald E. Redmond, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 16:11
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/415
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
37 words
The method of eliminating the withdrawal symptoms in an opiate-addicted human who has had methadone treatment, which comprises orally administering to said human an effective amount of 2-(2,6-dichloroanilino)-2-imidazoline or a non-toxic, pharmaceutically acceptable acid addition salt thereof.
Claim 2
Independent Claim
37 words
The method of eliminating the withdrawal symptoms in an opiate-addicted human who has had methadone treatment, which comprises orally administering to said human an effective amount of 2-(2,6-dichloroanilino)-2-imidazoline or a non-toxic, pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim
14 words
The method of claim 1, where said effective amount is 5 to 15 μg/kg.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-01-25 | 1985-07-27 | 1986-01-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-01-25 | 1989-07-27 | 1990-01-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-01-25 | 1993-07-27 | 1994-01-26 | $7700.00 | Window Closed / Lapsed |